Summary Sun Pharma has received DCGI approval to manufacture and market generic semaglutide for chronic weight management, to be sold under the brand Noveltreat after patent expiry in March 2026
Schedule a FREE New Patient Evaluation FDA Regulations and Guidelines Our team is committed to providing safe, responsible care
Hydrate aggressively before, during, and after exercise
(i) Required CEHRT Use We proposed our requirement for CEHRT use at 512.740(b)(1) that ASM participants are required to provide evidence, in a form and manner specified by CMS, demonstrating their use of CEHRT to fulfill the Promoting Interoperability measure requirements (as defined at 414.1305) and receive a score greater than zero percentage points for the Promoting Interoperability ASM performance category
With reduced appetite, ensuring adequate protein intake helps preserve muscle mass during weight loss, which is essential for maintaining a healthy metabolism and overall strength
Changes in vision: Let your provider know if your eyesight gets worse while using Ozempic